𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Response to tamoxifen in estrogen receptor-poor metastatic breast cancer

✍ Scribed by Charles L. Vogel; Dawn R. East; Walter Voigt; Sharon Thomsen

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
547 KB
Volume
60
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A METASTATIC BREAST TUMOR CELL LINE, GI-
A METASTATIC BREAST TUMOR CELL LINE, GI-101A, IS ESTROGEN RECEPTOR POSITIVE AND RESPONSIVE TO ESTROGEN BUT RESISTANT TO TAMOXIFEN
✍ JOSEPH J. MORRISSEY; SHULA RANEY πŸ“‚ Article πŸ“… 1998 πŸ› Elsevier Science 🌐 English βš– 190 KB

The progression of human breast cancer is often associated with a loss of estrogen dependence for growth, a resistance to estrogen antagonists such as tamoxifen, and the metastatic spread of the disease to secondary sites. Cell lines developed from such advanced breast tumors are often metastatic in

Influence of estrogen receptor status on
Influence of estrogen receptor status on response of metastatic breast cancer to aminoglutethimide therapy
✍ Dr. Bellarmine V. Lawrence; Allan Lipton; Harold A. Harvey; Richard J. Santen; S πŸ“‚ Article πŸ“… 1980 πŸ› John Wiley and Sons 🌐 English βš– 563 KB

Aminoglutethimide (AG) is an effective chemical ablative form of therapy for metastatic breast cancer in postmenopausal women. Estrogen receptor (ER) status in breast cancer is useful in predicting the response to the hormonal treatments. Of 134 postmenopausal metastatic breast cancer patients treat

Up-regulation of estrogen receptor by ta
Up-regulation of estrogen receptor by tamoxifen in human breast cancer
✍ Shinzaburo Noguchi; Kazuyoshi Motomura; Hideo Inaji; Shingi Imaoka; Hiroki Koyam πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 631 KB

Background. Influence of tamoxifen treatment on estrogen receptor (ER) and progesterone receptor (PR) levels in human breast cancer has not been fully elucidated in vivo. This problem was studied in 20 postmenopausal patients with ER-positive and PR-positive primary breast cancer. Each patient unde

Tamoxifen response following no response
Tamoxifen response following no response to orchiectomy in metastatic male breast cancer: A case report
✍ Dennis A. Hiluard; David W. Wilbur; Elber S. Camacho πŸ“‚ Article πŸ“… 1984 πŸ› John Wiley and Sons 🌐 English βš– 154 KB

A male patient with advanced breast cancer had no response to orchiectomy but subsequently enjoyed a 17-month partial response to tamoxifen 10 mg B.I.D. His tumor estrogen receptor (ER) protein was 555 fmol proteinhl cytosol. The potential role of ER determinations in the selection of therapy for ad